AZAndrey E. Zotikov

Andrey E. Zotikov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrey E. Zotikov has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coronary-Vertebral Collaterals in Takayasu Arteritis: Case Report

    by Andey V. Chupin, Andrey E. Zotikov, Aleksandra S. Kutovaya, Aleksandr L. Golovyuk, Aleksandr F. Kharazov, Vladimir A. Kul’bAk, Anzhelika V. Kozhanova, Aleksey B. Varava, Irina E. Tiimina

    INTRODUCTION: PNonspecific aortoarteritis is a rare autoimmune disease with the involvement and narrowing of the aorta and its branches leading to ischemia of the respective arterial region. In the territory of the Russian Federation, the most common manifestation of Takayasu nonspecific aortoarteritis is lesion of the branches of the aortic arch, which in rare cases leads to development of the so called bald arch syndrome. In response to hypoxia, intersystemic collaterals are formed through the neoangiogenesis or redirection of the blood flow from the occluded vessels to small-diameter vessels. In patients with bald arch syndrome, the key role in blood supply to the brain is played by the vertebral arteries. Here, collateral blood supply is realized through the intersystemic anastomoses, most often through the anastomotic leaks between the intercostal and internal thoracic arteries. In the literature, single cases of formation of collaterals between coronary and bronchial arteries are reported. The article presents a clinical case of coronary-vertebral anastomoses in a patient with extremely severe course of Takayasu arteritis with occlusion of the brachiocephalic trunk, right common carotid artery (CA), left common CA, right internal CA, left internal CA (bald arch syndrome). The probable cause of such course of the disease was late referral for medical help by the patient and lack of adequate basic therapy. CONCLUSION: The demonstrated case is the fourth case in the world literature describing the existence of collaterals between the coronary arteries and cerebral arteries, and the first case in the world describing the existence of collaterals from the right and left coronary arteries to the vertebral artery. Such unusual pathway of collateral blood supply in the patient is explained by the absence of the possibility for collateral compensation from the systems of subclavian and intercostal arteries, severe chronic cerebral ischemia. Usually, the causes of angina pectoris in patients with nonspecific aortoarteritis are spread of arteritis to the coronary arteries, insufficiency of the aortic valve, hypertrophy of the left ventricle. In the described case, none of these conditions was present, and angina can only be attributed to the existence of unusual collaterals and the development of a transient steal syndrome.


  • Long-Term Results of the Treatment of Patients With Chronic Ischemia of the Lower Limbs in Combination With Ischemic Heart Disease

    by B. G. Alekyan, N. G. Karapetyan, A. V. Chupin, A. E. Zotikov, A. B. Varava, Ju. B. Knish, M. A. Sedgaryan

    Aim      To compare long-term outcomes of x-ray endovascular (percutaneous coronary intervention, PCI, and lower limb angioplasty with stent placement, LLA; group 1) and combination treatments (PCI and open LLA surgery; group 2) in patients with chronic lower limb ischemia (CLLI) associated with ischemic heart disease (IHD). Material and methods  This retrospective study has been conducted in the Vishnevsky National Medical Research Center of Surgery since 2019. The study includes 92 patients with stage 2B CLLI associated with IHD who were managed from January 1, 2017 through December 31, 2020. Long-term outcomes were evaluated in 76 (82.6 %) patients. The endpoint was severe cardiovascular complications (CVC), including death, myocardial infarction, and acute cerebrovascular disease (ACVD). Results In group 1 during the long-term period, 1 (2.7%) fatal outcome due to pneumonia was observed. In group 2, 4 (10 %) patients died: 1 (2.5 %) patient due to ACVD, 1 (2.5 %) patient due to progression of oncological process, and 2 2 (5 %) patients due to COVID-19. Also, 2 (5.5 %) and 1 (2.5 %) cases of acute coronary syndrome (ACS) were observed in groups 1 and 2, respectively (p=0.61). Conclusion      In the x-ray endovascular (group1) and the combination (group 2) intervention groups, lethal outcomes due to myocardial infarction were absent. This fact confirms the importance of PCI in patients with CLLI for prevention of possible ACS in the long-term. Both therapeutic tactics in managing CLLI patients with IHD demonstrated high safety and clinical efficacy during the hospital and long-term periods and can be extensively used in routine clinical practice.

  • Open Access

    Current imaging techniques in large vessel vasculitis

    by T. V. Beketova, V. А. Zelenov, A. E. Zotikov

    Instrumental imaging modalities play an important role in the diagnosis, evaluation of treatment efficacy and early detection of recurrences in patients with large vessel systemic vasculitis (SV). There’s no currently available universal imaging modality yielding comprehensive information about large vessels regardless all spectacular progress in rheumatology with associated significant insights into SV pathogenesis, innovative therapeutic strategies and broadened diagnostic approaches. Therefore, standardization of instrumental methods in order to accurately assess the disease activity and recognize timely its’ relapse remains a pending issue in management of patients with large vessel SV.Published in 2018 the EULAR (European League Against Rheumatism) guidelines highlighted a wide range of problems concerning visualization of large vessel lesions in SV, resultant from a systematic analysis of up-to-date scientific achievements and clinical experience. The intent of this publication is to summarize the potential of available imaging modalities for patients with large vessel SV in the context of main provisions in the EULAR guidelines and discuss some controversial issues

  • Comparative characteristics of postoperative outcomes of different treatment strategies of patients with intermittent claudication in combination with coronary arteries disease

    by B. G. Alekyan, A. V. Pokrovskiy, N. G. Karapetyan, A. V. Chupin, A. B. Varava, A. E. Zotikov, A. Ya. Novak, Yu. B. Knish, M. A. Sedgaryan

    Aim      To compare in-hospital outcomes (severe cardiovascular complications, CVC) in patients with IIB stage chronic lower limb ischemia (CLLI) in combination with ischemic heart disease (IHD) in the following groups: stepwise percutaneous coronary intervention (PCI) and stenting and angioplasty of lower limb arteries (LLA) (group 1) and combination treatment, including PCI and open surgery on LLA (group 2). Material and methods  Since 2019, the A.V. Vishnevsky National Medical Research Center of Surgery has performed a retrospective study that includes patients with stage IIB CLLI in combination with IHD. Patients were divided into 2 groups: group 1 (n=46), stepwise X-ray endovascular treatment (PCI and stenting and angioplasty of LLA); group 2 (n=46), stepwise combination treatment (PCI and open surgery on LLA). The endpoint included severe CVCs (death, acute myocardial infarction, acute cerebrovascular disease) and severe complications in the LLA area (stent thrombosis, repeated intervention on LLA, amputation). Results In 198 surgeries, none of 92 patients had severe CVC, and no fatal outcomes were observed. In group 2, there was one (2.1 %) severe complication on LLA during the early postoperative period, for which a successful additional intervention was performed. Conclusion      Individualized approach to care of each patient with LLA pathology in combination with IHD helps avoiding severe CVCs at the hospital stage. It was shown that X-ray endovascular and combination treatments are safe and effective in the absence of fatal outcomes and acute disorders of coronary circulation at the hospital stage.


  • Reconstruction of renal vessels during extracorporeal partial nephrectomy of a single kidney

    by A.E. Zotikov, A.A. Gritskevich, Z.A. Adyrkhaev, T.P. Baitman, I.V. Miroshkina, Zh. Polotbek Uulu

    Почечно-клеточный рак с опухолевым тромбом представляет собой сложную хирургическую проблему. Рак единственной почки при наличии перспективы сохранения функции органа является показанием к нефронсохраняющей резекции почки. Операция ex vivo в данном случае может стать единственной альтернативой нефрэктомии. Хирургическое вмешательство в лечении почечно-клеточного рака эффективно, даже если возможна только циторедуктивная операция. Пятилетняя онкоспецифическая выживаемость таких пациентов составляет 40—60%. Органосохраняющая операция предпочтительна для пациентов, страдающих почечно-клеточным раком единственной почки, но не всегда достаточно радикальна. Мы представляем случай успешной органосохраняющей операции с применением экстракорпоральной методики резекции и реконструкцией сосудов почки у пациента с почечно-клеточным раком единственной почки и опухолевым тромбозом нижней полой вены.

  • Long-term outcomes of two treatment strategies for critical limb ischemia combined with coronary artery disease

    by B.G. Alekyan, N.G. Karapetyan, A.V. Chupin, A.E. Zotikov, A.B. Varava, A.A. Ushakov, L.G. Geletsyan, A.M. Norvardyan

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить отдаленные результаты двух стратегий лечения пациентов с КИНК в сочетании с ИБС. МАТЕРИАЛ И МЕТОДЫ Проведено одноцентровое ретроспективное исследование, включающее 102 пациента с КИНК в сочетании с ИБС, которым выполнялись вмешательства на обоих артериальных бассейнах с применением рентгенэндоваскулярных и хирургических технологий. Решение о методе и этапности реваскуляризации артерий принималось на заседании консилиума «сердечно-сосудистой команды». В зависимости от выбранной стратегии реваскуляризации обоих артериальных бассейнов больные были распределены на две группы: 1-я группа — рентгенэндоваскулярное лечение (этапное ЧКВ и ангиопластика артерий нижних конечностей, n=53; 50,3%); 2-я группа — комбинированное лечение (этапное ЧКВ в сочетании с открытой хирургией артерий нижних конечностей, n=49; 48,0%). Отдаленные результаты лечения пациентов в сроке от 7 до 51 мес (медиана 31,5 мес) изучены у 85 (85%) из 100 выписанных больных на основании повторных госпитализаций (13,0%), амбулаторных осмотров (34,2%), анализа анкетных данных и опроса по телефону (52,8%). РЕЗУЛЬТАТЫ Суммарная общая отдаленная летальность составила 14,1% (в 1-й группе — 13,6%, в 2-й группе — 14,6%; p=0,89). Суммарная кардиоваскулярная смертность имела показатель 7,0% (в 1-й группе — 6,8%, во 2-й группе — 7,3%; p=0,92). Суммарная смертность от других не сердечно-сосудистых причин — 7,0% (в 1-й группе — 6,8%, во 2-й группе — 7,3%; p=0,92). Частота инсультов в двух группах — 3,5% (в 1-й группе — 4,5%, во 2-й группе — 2,4%; p=0,59). Частота рецидива симптомов стенокардии в группе 1-й — 2,3%, во 2-й группе рецидивы не зафиксированы. Суммарная частота рецидива ишемии нижних конечностей — 7,0% (в 1-й группе — 9,0%, во 2-й группе — 5,0%; p=0,44). Суммарная частота ампутаций нижних конечностей — 3,5% (в 1-й группе — 4,5%, во 2-й группе — 2,4%; p=0,59). Нелетальных инфарктов миокарда не выявлено ни в одной из групп. ВЫВОДЫ 1. В отдаленном периоде наблюдения больных с КИНК и ИБС не отмечено достоверной разницы в результатах рентгенэндоваскулярного (1-я группа) и комбинированного методов лечения (2-я группа) по таким показателям, как сердечно-сосудистые осложнения и неблагоприятные события на артериях нижних конечностей (p>0,5). 2. В отдаленные сроки наблюдения суммарная общая летальность составила 14,1%, сердечно-сосудистая — 7,0%. Частота инсультов — 3,5%. Нелетальных инфарктов миокарда не выявлено ни в одной из групп. 3. Обе стратегии лечения больных с КИНК в сочетании с ИБС показывают высокую безопасность и клиническую эффективность на госпитальном и отдаленном периодах наблюдения и могут широко применяться в повседневной клинической практике.


  • Open Access

    Renal artery aneurysms

    by A. E. Zotikov, Z. A. Adyrkhaev, A. M. Solovyova

    Renal artery aneurysms are a rare condition and are usually found when other abdominal organ diseases are being searched. Among the causes of renal artery aneurysms, atherosclerosis and fibromuscular dysplasia predominate. However, they can also be observed in congenital Ehlers-Danlos syndrome, neurofibromatosis, arteritis, and due to traumatic effects. Most patients have an asymptomatic course of the disease. Literature data suggest slow growth of aneurysms, and their progression is associated with arterial hypertension, absence of wall calcification and pregnancy in young women. The aim of surgical treatment is to prevent aneurysm rupture, eliminate the risk of renal parenchyma embolism and correct arterial hypertension. Most authors believe that surgical treatment is indicated for asymptomatic course of the disease when the aneurysm is over 20 mm in diameter, aneurysm growth is over 5 mm within a year, arterial hypertension resistant to drug therapy, renal artery dissection and aneurysm presence in women of childbearing age. There are a number of surgical and endovascular techniques to restore renal blood flow. Both open and endovascular interventions are used for renal artery trunk surgery. For aneurysms of the renal artery branches, aortorenal shunting by autovenous or internal iliac artery as well as extracorporeal surgeries are more often used. The use of endografts is most appropriate for localization of aneurysms in the renal artery trunk, while embolization with microspirals and glue is most effective for saccular aneurysms. The embolization technique can cause embolization of the renal parenchyma itself as a potential complication, which aggravates arterial hypertension. The authors present the literature and their own data on various techniques to restore the renal blood flow. Up to 80-90% of the operated kidneys can be saved in the long term. Reconstructive surgery reduces the level of arterial pressure and reduces the number of antihypertensive drugs used and the need for renal replacement therapy.


  • Open Access

    A case of successful surgical treatment of a ruptured giant aneurysm of the infrarenal aorta in an elderly patient

    by A. E. Zotikov, M. R. Khokonov, K. Kh. Eminov, A. M. Solovieva, A. V. Kozhanova, V. S. Ostapenko, A. Yu. Shchedrina, E. V. Chebotareva, Д. Л. Ликальтер, A. Yu. Molchanova, et al.

    Today, abdominal aortic aneurysm surgery is a fairly well-studied area of medicine. Nevertheless, some questions remain rather debatable. No clear criteria for giant aneurysms have been developed so far. The available foreign and domestic literature reports about 40 cases of surgical treatment of giant abdominal aortic aneurysms, 16 of which are cases of aneurysm rupture. Open surgery remains the method of choice in the treatment of giant aneurysms due to the pronounced technical difficulties of endovascular intervention. The authors present a case of successful surgical treatment of a giant aneurysm rupture in an elderly patient. The peculiarity of this patient's condition is the occurrence of aneurysm rupture after hospital admission. The patient refused surgical treatment for two years after aneurysm detection. On examination after admission, multispiral computed tomography revealed an aneurysm size of 101 mm. On the eve of surgery, pain syndrome in the left abdomen and tachycardia appeared. Aneurysm rupture was suspected and the patient was urgently admitted to the operating room. The surgery was performed under the conditions of machine reinfusion of autoblood. The patient underwent abdominal aortic aneurysm resection with linear prosthesis and retroperitoneal hematoma removal. The postoperative period had no peculiarities. On the 10th day after the operation the patient was discharged in satisfactory condition to the outpatient treatment. This clinical case demonstrates the possibility of successful surgical treatment of giant aneurysm rupture in elderly patients.

  • Additional vascularization of the omental flap using mammary-gastroepiploic bypass grafting in the treatment of deep sternal wound infection

    by A.A. Pechetov, A.E. Zotikov, G.G. Karmazanovsky, D.A. Volchansky, V.A. Kulbak

    Частота развития стерномедиастинита зависит от множества факторов риска и в среднем составляет 8%. С целью лечения пациентов этой категории применяют этапные хирургические обработки с местным ведением раны для достижения ее стерильности. В редких случаях при тотальном поражении грудины на фоне остеопороза кости с множественными переломами выполняют стернумэктомию или субтотальную резекцию грудины, что обусловливает формирование обширного дефекта грудной стенки. Заключительным этапом является реконструкция передней грудной стенки. Среди наиболее популярных способов реконструкции лидирующие позиции занимают различные методики аутопластики дефекта. Представляем клиническое наблюдение пациента со стерномедиастинитом, которому проведено этапное лечение, а на завершающем этапе выполнена субтотальная стернумэктомия с одномоментной оментопластикой. В дистальном бассейне правой желудочно-сальниковой артерии сформирован анастомоз с правой внутригрудной артерией с целью дополнительной васкуляризации перемещенного трансплантата большого сальника. В изученной нами литературе мы не нашли описания подобной операции в лечении стерномедиастинита. Прослежены отдаленные результаты лечения — более 50 мес безрецидивного функционального благополучия пациента со стороны средостения и передней грудной стенки.


  • Open Access

    Parnaparin in surgery, vascular surgery and associated disciplines

    by D. A. Lavrentyev, A. E. Zotikov

    Aliterature review is dedicated to the use of Parnaparin in various surgical specialties. Prevention and treatment of thromboembolic complications is the major indication for the use of Parnaparin. In the review, the authors dwell on comparative studies of the efficacy oflow molecular weight heparins and unfractionated heparin. They also discuss in detail pharmacokinetics and pharmacodynamics of Parnaparin, its structure and effect on hemostasis components. Due tolack of direct comparative studies of variouslow molecular weight heparins, the authors provide reviews based on the network meta-analysis, which allowed them to identify the advantages of a specificlow molecular weight heparin by indirect comparison.There are few direct comparative studies of variouslow molecular weight heparins in theliterature, which does not allow for an objective assessment of their advantages and disadvantages. The authors do not only provideliterature data on direct comparative studies, but also show data on indirect comparisons (network meta-analysis). They analysed the efficacy of Parnaparin and otherlow molecular weight heparins for the prevention of thromboembolic complications, treatment of deep vein thrombosis and post-thrombophlebitic syndrome. The issues of the efficacy of Parnaparin in chronic arterial insufficiency and use in acute coronary syndrome are highlighted separately. The final part of the review is concerned with a promising, butlittle-known area of prophylaxis of restenosis and prevention of atherosclerosis progression. Experimental studies have allowed us to state that Parnaparin is one of the most effectivelow molecular weight heparins as far as thromboembolic complications are concerned. Parnaparin significantly reduces frequency of DVT events and, at the same time, decreases major bleeding risk as compared with unfractionated heparin. No dose adjustment is required in obese patients. Dose adjustments are based not on body weight but on risk factors for thrombosis, and obesity is only one of them to be considered to choose a dose. Amonglow molecular weight heparins, Parnaparin is one of the most potent drugs that reduces the proliferative and migratory capacity of smooth muscle cells; however, further research is needed to assess the prospects of using Parnaparin for the prevention of restenosis.